Intelligence » Top Posts » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

The Link Between Sugar and Depression

Thursday, August 17, 2017 -- By Dr. Mercola Foods have an immense impact on your brain, and eating whole foods as described in my nutrition plan is the best way to support both your physical and mental health. Based on the evidence, avoiding sugar (particularly fructose) is an important prevention and treatment strategy for anxiety and depression, both of which are rising in prevalence. A number of studies have linked high-sugar diets to a higher risk of depression. Most recently, men consuming more than 67 grams of sugar per day were found to be 23 percent more likely to develop anxiety or depression over the course of five years compared to those whose sugar consumption was less than 40 grams per day.1,2,3 This held

HPV-related oral cancers have risen significantly in Canada: study

Monday, August 14, 2017 -- The proportion of oral cancers caused by the human papillomavirus has risen significantly in Canada, say researchers, who suggest the infection is now behind an estimated three-quarters of all such malignancies.

Forever Labs preserves young stem cells to prevent your older self from aging

Thursday, August 17, 2017 -- Stem cells have the potential to become any type of cell needed in the body. Forever Labs, a startup in Y Combinator’s latest batch, is preserving adult stem cells with the aim to help you live longer and healthier. Read More

Vitamin C may stop leukemia from progressing

Thursday, August 17, 2017 -- New research finds that high-dose vitamin C can genetically 'reprogram' leukemic cells to mature and die normally, instead of replicating to cause cancer.

Activating Hair Stem Cells Could Stop Male Pattern Baldness

Thursday, August 17, 2017 -- Researchers at UCLA found that stimulating stem cells in hair could restore growth.

FDA approves Pfizer's drug for rare blood cancer

Thursday, August 17, 2017 -- (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's rare blood cancer drug, Besponsa, with a boxed warning.

Ebola virus survives for two years in the semen of infection survivors

Tuesday, August 15, 2017 -- (Natural News) Researchers at the University of North Carolina (UNC) at Chapel Hill have recently discovered that the Ebola virus ribonucleic acid (RNA) remains in the semen of Ebola survivors even after two years of recovery. In a study that was published on Saturday, July 22 in Open Forum Infectious Diseases, researchers found out that even... Read More

Big Pharma just developed a way to medicate unborn babies with prescription drugs ... Will they be treated with antidepressants?

Wednesday, August 16, 2017 -- (Natural News) Researchers from the Swiss Federal Laboratories for Materials Science and Technology (EMPA) have developed a three-dimensional cell model of a human placental barrier that is being used to study how substances like nanoparticles can cross the placental barrier. Even small doses of toxic substances can be very harmful to a fetus, which is... Read More

New treatment may reduce the side effects of chemotherapy: study

Saturday, August 12, 2017 -- Australian researchers may have found a treatment to combat a serious side effect of chemotherapy treatments prescribed for cancer patients. Their research, which was conducted on rodents, will now go on to clinical trials on humans.

Insufficient sleep raises type 2 diabetes risk in children

Wednesday, August 16, 2017 -- A new study suggests that as little as 1 hour of less sleep per night significantly raises children’s risk of developing type 2 diabetes.

Stroke, Heart Attack Damage Could Be Mitigated via Mimicry of Good Cholesterol

Wednesday, August 16, 2017 -- It may be a caricature, but it is recognized by ailing blood vessels, which respond by moving closer to a picture of cardiovascular health. The “it” is an artificial protein called ApoM-Fc that mimics apolipoprotein M (ApoM), a natural protein that is a component of high-density lipoprotein (HDL), or “good cholesterol.” ApoM-Fc performs better than synthetically derived ApoM, which is expensive to produce and has just a 15-minute half-life in the body’s bloodstream. In tests on mice, ApoM-Fc lowered blood pressure and alleviated tissue damage caused by stroke, heart attack, and other cardiovascular diseases. ApoM-Fc, like ApoM, ferries S1P, or sphingosine-1-phosphate , particles through the bloodstream to endothelial cells, which line the blood vessels and are studded with S1P

Meningitis jab uptake 'worryingly low'

Tuesday, August 15, 2017 -- School-leavers are being urged to be immunised against the highly aggressive strain.

Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End

Thursday, August 17, 2017 -- Corbus Pharmaceuticals plans to start a Phase 2b clinical trial of anabasum as a cystic fibrosis treatment by the end of 2017. The decision follows positive results of a Phase 2 study, the company said. Anabasum was formerly known as JBT-101 or Resunab. A Phase 2a trial usually looks at a drug’s effectiveness in a small number of patients, while the goal […] The post Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End appeared first on Cystic Fibrosis News Today.

Breast Cancer (Invasive) Treatment Regimens

Wednesday, August 16, 2017 -- The latest breast cancer treatment regimens with detailed drug information such as pertuzamab with trastuzumab and docetaxel.

Hair growth stimulated using stem cells

Monday, August 14, 2017 -- Using 3-D organoids made from stem cells, scientists managed to uncover a six-step process by which hair grows and stimulated hair growth.

Dementia and low brain serotonin may be linked: Study finds

Tuesday, August 15, 2017 -- Johns Hopkins researchers looked into the brain scans of persons with mild loss of thought and memory and have found that they have significantly low levels of serotonin in their brains. Serotonin is a natural brain chemical that is responsible for several functions including mood, sleep and appetite and also is important for several mental health conditions.

CSU test differentiates Lyme disease from STARI

Thursday, August 17, 2017 -- Lyme disease is the most commonly reported vector-borne illness in the United States, but it can be confused with similar conditions, including Southern Tick-Associated Rash Illness (STARI). A team of researchers led by Colorado State University has identified a way to distinguish Lyme disease from similar conditions, according to a new study published Aug. 16 in Science Translational Medicine. […] The post CSU test differentiates Lyme disease from STARI appeared first on Outbreak News Today.

Galapagos Therapy GLPG1690 Excels in Phase 2 IPF Trial, Spurring Further Development

Monday, August 14, 2017 -- GLPG1690, an investigational therapy developed by Galapagos to treat idiopathic pulmonary fibrosis (IPF), prevented further lung decline in a Phase 2a trial, allowing the Belgian pharmaceutical firm to rapidly move forward with the clinical development of this therapy. The trial, called FLORA (NCT02738801), involved randomly assigning 17 IPF patients treatment with GLPG1690 and six with placebo. Although the exploratory study […] The post Galapagos Therapy GLPG1690 Excels in Phase 2 IPF Trial, Spurring Further Development appeared first on Pulmonary Fibrosis News.

Type 2 diabetes rise in children 'disturbing'

Saturday, August 12, 2017 -- More than 600 children and teenagers are being treated for the condition in England and Wales, experts warn.

Under-skin transplants show promise for type 1 diabetes

Wednesday, August 16, 2017 -- Using tissue engineering, researchers show a way forward for treating type 1 diabetes by implanting insulin-producing islet cells under the skin.